Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest announcement is out from Resonance Health Ltd ( (AU:RHT) ).
Resonance Health Ltd announced its full-year financial results for FY25 and provided guidance for FY26. The company is hosting a live investor briefing to discuss these results, which reflects its ongoing commitment to innovation and quality in healthcare technology. This announcement is significant for stakeholders as it highlights Resonance Health’s strategic direction and potential growth in the healthcare technology sector.
More about Resonance Health Ltd
Resonance Health is an Australian healthcare technology and services company, known for its Software-as-Medical Devices (SaMDs) that are used globally by clinicians and pharmaceutical companies. The company specializes in non-invasive MRI-based assessments for various health conditions, including liver iron concentration and liver fat, and has regulatory clearances in the USA, Europe, UK, and Australia.
Average Trading Volume: 324,489
Technical Sentiment Signal: Sell
Current Market Cap: A$19.3M
For an in-depth examination of RHT stock, go to TipRanks’ Overview page.